Weight loss
in New York.
Weight-loss practice marketing in New York, where Manhattan premium GLP-1 pricing, dense borough competition, and concentrated regulatory attention define the competitive field.
How weight-loss practices
actually grow here.
Manhattan Upper East Side carries the premium GLP-1 practice tier; Midtown is commuter volume. Brooklyn, Queens, and Westchester are distinct submarkets. Compounded-semaglutide marketing is actively scrutinized by state and federal regulators here.
Market note, New York. Largest U.S. metro. Manhattan concierge and aesthetic markets are the global reference point for luxury healthcare. Brooklyn, Queens, Westchester, and Long Island each behave as distinct sub-markets with their own competitive fields.
- ·NewYork-Presbyterian
- ·NYU Langone Health
- ·Mount Sinai Health System
- ·Memorial Sloan Kettering Cancer Center
For a New York weight loss practice:
Dominance.
Largest and most regulated GLP-1 market in the country. Dominance tier required for compliance and competitive positioning.
Upper East Side concierge-adjacent weight-loss practices, Manhattan aesthetic-GLP-1 hybrids, and borough-anchored medical weight-loss clinics.
New York weight loss
questions, answered.
- How actively is NY State regulating compounded semaglutide marketing?
- Very actively. State AG actions, pharmacy board oversight, and NYC health department attention all focus on compounded GLP-1 marketing. Any content referencing compounded semaglutide or tirzepatide should be reviewed by healthcare counsel before publication; claims around FDA-approval status, pharmacy sourcing, and pricing all draw scrutiny.
- Are you current on GLP-1 compliance?
- Yes. Every campaign runs through the current federal and state compliance posture. We stay current with FDA shortage list changes, compounding restrictions, platform advertising policies, and insurance-carrier language requirements.
- Can compounded GLP-1s be advertised on Meta or Google in 2026?
- It depends on the current policy state, which has shifted multiple times since 2023. We maintain working relationships with both platforms' healthcare policy teams. The right answer this quarter is not the right answer last quarter.
- What's the typical LTV that makes the math work?
- Medication-based programs: $2,500 to $6,000 patient LTV. Counseling-only programs: $800 to $2,500. We calibrate customer acquisition cost targets against the midpoint of whichever model the practice runs.
- Do you work with insurance-accepted weight loss clinics?
- Yes. The marketing is different: slower cycle, higher volume, lower allowable CAC. We build accordingly and don't pretend cash-pay and insurance-pay economics are the same.
- How do you handle program retention?
- Retention is the business in this vertical. We build automated check-in sequences, refill reminders, plateau-phase content, and offer-structure work that keeps patients engaged through the first ninety days (the highest drop-off window).
- Do you write medical compliance language?
- No. We audit existing language and flag issues. We don't draft compliance language directly; that's your medical director's domain and it needs to stay there.
One New York audit,
one honest recommendation.
The Practice Audit reads your domain against the weight-loss practices playbook and the New York competitive field. Three minutes, honest number, honest recommendation.
Not ready for the full audit?
Just say hi.
If you'd rather not run the Practice Audit yet, leave a shorter version here. Vince reads every New York submission personally and replies within a business day.